Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients ; volume:22 ; number:1 ; day:26 ; month:6 ; year:2020 ; pages:1-2 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (26.6.2020), 1-2, 12.2020
- Creator
-
Nived, Per
Jönsson, Göran
Settergren, Bo
Einarsson, Jon
Olofsson, Tor
Jørgensen, Charlotte Sværke
Skattum, Lillemor
Kapetanovic, Meliha C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02256-2
- URN
-
urn:nbn:de:101:1-2020082722371046546142
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nived, Per
- Jönsson, Göran
- Settergren, Bo
- Einarsson, Jon
- Olofsson, Tor
- Jørgensen, Charlotte Sværke
- Skattum, Lillemor
- Kapetanovic, Meliha C.
- SpringerLink (Online service)
Other Objects (12)
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Pneumococcal vaccination in diabetic patients: review from clinical practice
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Correspondence relative to vaccination
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination
Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
Low pneumococcal vaccination among pPatients with psoriasis in Germany: results from Vac-Pso
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Pneumococcal vaccination in diabetic patients: review from clinical practice
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Correspondence relative to vaccination
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination
Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
Low pneumococcal vaccination among pPatients with psoriasis in Germany: results from Vac-Pso
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients
Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
Pneumococcal vaccination in diabetic patients: review from clinical practice
Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
Pneumococcal vaccination in children with underlying conditions
Correspondence relative to vaccination
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination
Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination